Navigation Links
Isis Pharmaceuticals Announces Redemption Of 2 5/8% Convertible Subordinated Notes Due 2027
Date:8/13/2012

CARLSBAD, Calif., Aug. 13, 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it has delivered a notice of redemption relating to all of its outstanding 2 ⅝% Convertible Subordinated Notes due 2027 (the "2027 Notes") at a redemption price of 100.75% of the principal amount thereof.  As of August 13, 2012, $162,500,000 aggregate principal amount of the 2027 Notes was outstanding.  The 2027 Notes will be redeemed on September 12, 2012 unless earlier converted.  The CUSIP Numbers of the 2027 Notes are 464337AD6 and 464337AE4.

The 2027 Notes are convertible at any time prior to 5:00 p.m. Eastern Time, September 11, 2012 at a rate of 68.3761 shares of common stock per $1,000 principal amount of the 2027 Notes converted.  If any 2027 Notes are surrendered for conversion, the conversion will be settled in cash.

Wells Fargo Bank, N.A., the trustee for the 2027 Notes, is delivering a Notice of Redemption to all registered holders of the 2027 Notes on August 13, 2012.  Copies of such Notice of Redemption and additional information relating to the procedure for redemption and/or conversion of the 2027 Notes may be obtained from the Wells Fargo Bank, N.A., by calling (800) 344-5128.

ABOUT ISIS PHARMACEUTICALS, INC.
Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 25 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer.  Isis' partner, Genzyme, plans to commercialize Isis' lead product, KYNAMRO™, following regulatory approval.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cadence Pharmaceuticals To Present At The Wedbush PACGROW Life Sciences Management Access Conference In New York City On August 14, 2012
2. Lexicon Pharmaceuticals To Present At The Wedbush PacGrow 2012 Management Access Conference
3. Intercept Pharmaceuticals Closes $30 Million Series C Financing
4. Inovio Pharmaceuticals Reports 2012 Second Quarter Financial Results
5. AcelRx Pharmaceuticals Reports Second Quarter 2012 Financial Results
6. Arena Pharmaceuticals Announces Second Quarter 2012 Financial Results and Recent Developments
7. Sales Force Effectiveness in Pharmaceuticals - Targeted Sales Models such as Enhanced Key Account Management (KAM) and Closed-Loop Marketing (CLM) Strategies Drives Sales Force Efficiency
8. Isis Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Growth Conference
9. Actinium Pharmaceuticals and Philogen S.p.A. Announce Collaboration for Alpha Therapy Based Antiangiogenesis Program
10. Isis Pharmaceuticals Prices Offering of $201.25 Million of 2 3/4% Convertible Senior Notes, Including Exercise in Full of Over-Allotment Option
11. Optimer Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)...   Intarcia Therapeutics, Inc. today announced its ... Sessions of the American Diabetes Association taking place June ... the Boston Convention and Exhibition Center. The presentations span ... currently marketed and investigational therapies on patients with type ... late-stage clinical candidate, ITCA 650. , Saturday ...
(Date:6/3/2015)... , June 02, 2015 Research ... addition of the "2015 Strategies in the ... their offering. Highlights of the Report ... the US tumor marker testing market. , ... as well as key economic, regulatory, demographic, social ...
(Date:6/3/2015)... BARBARA, Calif. , June 3, 2015  The ... formal endorsement of a Midwife Kit as a standard ... Kit was developed by Direct Relief in consultation with ... of charge to midwives in developing countries. ... from complications related to their pregnancy or childbirth.  Skilled ...
Breaking Medicine Technology:Intarcia To Announce Key ITCA 650 Phase 3 Findings And Other Data Presentations At Upcoming 75th Scientific Sessions of the American Diabetes Association In Boston 2Intarcia To Announce Key ITCA 650 Phase 3 Findings And Other Data Presentations At Upcoming 75th Scientific Sessions of the American Diabetes Association In Boston 3Intarcia To Announce Key ITCA 650 Phase 3 Findings And Other Data Presentations At Upcoming 75th Scientific Sessions of the American Diabetes Association In Boston 4United States Strategies in the Tumor Marker Testing Market 2015 2A Kit for Every Midwife: International Confederation of Midwives Endorses Direct Relief-Developed Midwife Kit as Global Standard 2A Kit for Every Midwife: International Confederation of Midwives Endorses Direct Relief-Developed Midwife Kit as Global Standard 3A Kit for Every Midwife: International Confederation of Midwives Endorses Direct Relief-Developed Midwife Kit as Global Standard 4
(Date:6/3/2015)... Loma Linda University Health and Adventist Health ... Memorial Hospital (SGMH). The SGMH board voted unanimously to ... “Loma Linda University Health has been serving the Pass ... officer, Loma Linda University Medical Center. “We are thrilled ... this community.” , Under the proposed affiliation, Loma ...
(Date:6/3/2015)... NY (PRWEB) June 03, 2015 Johnson ... to pay $7.8 million to resolve a Risperdal lawsuit ... over tactics the company allegedly used to market the ... Circuit Court indicate that the Arkansas Attorney General moved ... of the accord. The Risperdal settlement amounts to just ...
(Date:6/3/2015)... 2015 The National Resident Matching Program ... C. Savoia, M.D., Dean of Medical Education at the University ... Chair on July 1. , “It is an ... Resident Matching Program,” said Dr. Savoia. “NRMP’s goal is ... medical students with training programs, and I welcome the opportunity ...
(Date:6/3/2015)... On the heels of a report predicting ... ( click here to review news coverage about the ... has the talent to become a world-leading center of ... other biological data are collected and analyzed to help scientists ... the elements of a perfect storm for bioinformatics leadership,” said ...
(Date:6/3/2015)... Jersey (PRWEB) June 03, 2015 Horizon Blue ... Diversity MBA Magazine as one of the nation’s top employers ... BCBSNJ No. 6 among its national list of Best Places ... BNCBSNJ as the No. 1 Regional Company. This is ... by Diversity MBA Magazine for its diverse workplace policies and ...
Breaking Medicine News(10 mins):Health News:Loma Linda University Health and Adventist Health Enter into Exclusive Affiliation Negotiations with San Gorgonio Memorial Hospital 2Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 2Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 3Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 4Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 2Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 3Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 4Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 3Health News:Horizon Blue Cross Blue Shield of New Jersey Named a 2015 Best Place for Diverse Managers and Women to Work by Diversity MBA Magazine 2
... Jan. 7 The following is a statement by ... of the State address put forth recommendations on a ... care and financial security of New Yorkers of all ... Family Health Plus Program to 200 percent of the ...
... Whether low levels would work for ER patients with ... -- Going to the world,s most elevated natural laboratory, ... medical rules about the amount of oxygen needed by ... people can tolerate extremely low levels of oxygen, much ...
... known as Emily,s Law, has received Governor Ted Strickland,s ... of Ohio. Named after Emily Jerry, Emily,s Law will ... law, which was originally sponsored by Senator Tim Grendell, ... Association. Emily,s Story , Emily Jerry died at ...
... Provide Support and Convenience CARLSBAD, Calif., Jan. 7 ... a new on-line service for physicians and patients ... products. The new Web site, www.skinmedica.com , ... while offering the convenience of on-line information and ...
... WESTCHESTER, Ill., Jan. 7 BrainLAB, Inc., ... medical treatments,announces a new, customer-focused sales and ... growth and an expanding product,portfolio. , ... and support structures, customers will benefit,from a ...
... AR, AZ, CO, FL, LA, NM and TXBOISE, Idaho, ... its Albertsons Rx-tra Savings prescription discount program ... a 90-day supply of over 500 generic drugs. ... its formulary of over 500 drugs that are already ...
Cached Medicine News:Health News:Study of Everest Climbers Questions Oxygen Use 2Health News:Study of Everest Climbers Questions Oxygen Use 3Health News:Emily's Law for Regulating Pharmacy Technicians Signed by Ohio Governor 2Health News:Emily's Law for Regulating Pharmacy Technicians Signed by Ohio Governor 3Health News:SkinMedica Launches On-Line Service for Physician Partners 2Health News:BrainLAB, Inc. Announces New, Streamlined Surgery Business Division 2Health News:Albertson's LLC Launches $10.99 for 90-day Supply of Generic Drugs as Part of Rx-tra Savings Prescription Discount Program 2
The Wellwash 4 Mk 2 combines high performance and flexibility with reliability, simplicity and ease of use....
... is the newest addition to the Primus ... the unbeatable combination of speed and accuracy ... or moderate volume testing. Test results in ... technology for the lab or clinic., ,The ...
... HbA1c Testing , Monoclonal antibody method ... , Correlation study shows 99% agreement with ... can count on a CV of ... National Glycohemoglobin Standardization Program (NGSP) certified method, ...
... M-4 is a manual hemostasis analyzer ... clotting assays - PTs, aPTTs, thrombins, ... easy, inexpensive, low-volume testing, this analyzer ... on features, offering time and labor ...
Medicine Products: